Page 2 - Optimizerx Co News Today

OptimizeRx Co. (NASDAQ:OPRX – Get Rating) has received an average rating of “Moderate Buy” from the seven brokerages that are presently covering the company, MarketBeat Ratings reports. One analyst has rated the stock with a hold recommendation and six have given a buy recommendation to the company. The average 1-year price target among brokers that […]

Federated Hermes Inc. raised its holdings in OptimizeRx Co. (NASDAQ:OPRX – Get Rating) by 785.4% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 113,520 shares of the company’s stock after buying an additional 100,698 shares during the period. Federated Hermes Inc.’s holdings in OptimizeRx […]

Equities research analysts forecast that OptimizeRx Co. (NASDAQ:OPRX – Get Rating) will announce sales of $17.60 million for the current quarter, Zacks Investment Research reports. Three analysts have provided estimates for OptimizeRx’s earnings, with the highest sales estimate coming in at $17.94 million and the lowest estimate coming in at $17.15 million. OptimizeRx posted sales […]

Equities analysts predict that OptimizeRx Co. (NASDAQ:OPRX – Get Rating) will announce sales of $17.60 million for the current fiscal quarter, according to Zacks. Three analysts have made estimates for OptimizeRx’s earnings, with estimates ranging from $17.15 million to $17.94 million. OptimizeRx reported sales of $13.63 million in the same quarter last year, which indicates […]

Wall Street brokerages forecast that OptimizeRx Co. (NASDAQ:OPRX – Get Rating) will post $14.49 million in sales for the current fiscal quarter, Zacks Investment Research reports. Three analysts have provided estimates for OptimizeRx’s earnings, with estimates ranging from $13.68 million to $15.19 million. OptimizeRx reported sales of $11.23 million during the same quarter last year, […]

Analysts forecast that OptimizeRx Co. (NASDAQ:OPRX – Get Rating) will report earnings of $0.19 per share for the current quarter, Zacks reports. Three analysts have made estimates for OptimizeRx’s earnings. The lowest EPS estimate is $0.18 and the highest is $0.19. OptimizeRx reported earnings per share of $0.03 in the same quarter last year, which […]

OptimizeRx Co. (NASDAQ:OPRX – Get Rating) – Equities research analysts at William Blair raised their Q3 2023 earnings estimates for shares of OptimizeRx in a research report issued on Tuesday, March 29th. William Blair analyst R. Daniels now forecasts that the company will earn $0.20 per share for the quarter, up from their prior forecast […]

OptimizeRx Co. (NASDAQ:OPRX – Get Rating) gapped down before the market opened on Wednesday . The stock had previously closed at $41.37, but opened at $40.20. OptimizeRx shares last traded at $40.05, with a volume of 835 shares traded. Several research firms have weighed in on OPRX. TheStreet lowered shares of OptimizeRx from a “b-” […]

Precision Wealth Strategies LLC increased its stake in OptimizeRx Co. (NASDAQ:OPRX – Get Rating) by 61.6% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 9,929 shares of the company’s stock after acquiring an additional 3,783 shares during the quarter. Precision Wealth Strategies LLC owned […]

Wall Street brokerages predict that OptimizeRx Co. (NASDAQ:OPRX – Get Rating) will report $14.92 million in sales for the current fiscal quarter, Zacks Investment Research reports. Three analysts have made estimates for OptimizeRx’s earnings, with the highest sales estimate coming in at $15.19 million and the lowest estimate coming in at $14.60 million. OptimizeRx reported […]